Quince Therapeutics, Inc.QNCXNASDAQ
Loading
Shares Out (Diluted) Over TimeExpanding
Percentile Rank100
3Y CAGR+13.3%
5Y CAGR+17.8%
Year-over-Year Change
Weighted average diluted shares outstanding
3Y CAGR
+13.3%/yr
vs +8.4%/yr prior
5Y CAGR
+17.8%/yr
Recent deceleration
Acceleration
+5.0pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
2.3x
Strong expansion
Streak
5 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2024 | 43262269.00 | +16.2% |
| 2023 | 37237149.00 | +11.2% |
| 2022 | 33496533.00 | +12.7% |
| 2021 | 29718506.00 | +1.9% |
| 2020 | 29176232.00 | +53.3% |
| 2019 | 19031940.00 | -11.7% |
| 2018 | 21551160.00 | 0.0% |
| 2017 | 21551160.00 | - |